The Investment Whisperer
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

The Investment Whisperer

Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin June 4, 2025
June 4, 2025
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
5 Biggest Blockchain ETFs in 2025
next post
Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case

Related Posts

Matt Geiger: Hard Assets at Turning Point, How...

August 20, 2025

Quimbaya Gold Inc. Announces Participation in THE Mining...

May 31, 2025

Jeff Clark: Gold, Silver Price Drop — Cash...

February 2, 2026

5 Best-performing Canadian Uranium Stocks of 2025

August 6, 2025

Zeni Resources

February 6, 2024

Cardiol Therapeutics Announces Exercise and Closing of Over-Allotment...

October 12, 2024

Editor’s Picks: Miners Rescued, US Mine Waste Strategy,...

July 26, 2025

Crypto Market Update: Bitcoin Price Retreats Again After...

February 28, 2026

First Quantum Introduces Voluntary Retirement Scheme Amid Cobre...

September 18, 2024

Manuka Resources: Near-term Production from Gold and Silver...

May 29, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (1,627)
    • Investing (5,287)
    • Politics (7,046)
    • World (4,762)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheInvestmentWhisperer.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 TheInvestmentWhisperer.com | All Rights Reserved